CareDx, Inc.
$21.29
▲
2.46%
2026-04-21 05:57:01
caredx.com
NGM: CDNA
Explore CareDx, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.11 B
Current Price
$21.29
52W High / Low
$23.24 / $10.96
Stock P/E
—
Book Value
$5.95
Dividend Yield
—
ROCE
-7.75%
ROE
-6.27%
Face Value
—
EPS
$-0.4
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
761
Beta
2.54
Debt / Equity
8.64
Current Ratio
2.86
Quick Ratio
2.56
Forward P/E
14.7
Price / Sales
2.17
Enterprise Value
$671.01 M
EV / EBITDA
-86.08
EV / Revenue
1.77
Rating
None
Target Price
$24.8
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Twist Bioscience Corporation | $61.88 | — | $3.79 B | — | -24.75% | -16.79% | $62.09 / $23.3 | $7.44 |
| 2. | XWELL, Inc. | $1.2 | — | $9.7 M | — | -75.03% | -275.96% | $2.2 / $0.26 | $-1.1 |
| 3. | Inotiv, Inc. | $0.29 | — | $9.46 M | — | -17.26% | -49.76% | $3.32 / $0.22 | $3.17 |
| 4. | GeneDx Holdings Corp. | $69.71 | — | $1.92 B | — | -3.15% | -7.6% | $170.87 / $55.17 | $10.54 |
| 5. | Natera, Inc. | $206.53 | — | $29.47 B | — | -15.84% | -14.32% | $256.36 / $131.81 | $12.26 |
| 6. | Personalis, Inc. | $6.34 | — | $663.37 M | — | -29.9% | -35.02% | $11.5 / $3.09 | $2.55 |
| 7. | NeoGenomics, Inc. | $8.23 | — | $1.06 B | — | -6.93% | -12.43% | $13.74 / $4.72 | $6.49 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 108.39 M | 100.06 M | 86.68 M | 84.69 M | 86.58 M | — |
| Operating Profit | -6.04 M | -0.25 M | -10.77 M | -8.01 M | -19.89 M | — |
| Net Profit | -4.11 M | 1.68 M | -8.57 M | -10.35 M | 78.01 M | — |
| EPS in Rs | -0.08 | 0.03 | -0.17 | -0.2 | 1.52 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 379.81 M | 333.79 M | 280.32 M | 321.79 M |
| Operating Profit | -25.07 M | -55.53 M | -107.06 M | -77.23 M |
| Net Profit | -21.35 M | 52.55 M | -190.28 M | -76.61 M |
| EPS in Rs | -0.42 | 1.03 | -3.72 | -1.5 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 413.23 M | 491.05 M | 466.83 M | 542.99 M |
| Total Liabilities | 110.13 M | 112.62 M | 205.5 M | 112.08 M |
| Equity | 303.1 M | 378.43 M | 261.33 M | 430.91 M |
| Current Assets | 257.13 M | 351.83 M | 313.71 M | 387.85 M |
| Current Liabilities | 89.85 M | 89.37 M | 78.07 M | 75.97 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 42.03 M | 38.05 M | -18.39 M | -25.24 M |
| Investing CF | 2.16 M | -0.48 M | 40.45 M | -228.5 M |
| Financing CF | -93.39 M | -5.61 M | -29.61 M | -4.54 M |
| Free CF | 35.44 M | 31.56 M | -27.63 M | -49.57 M |
| Capex | -6.59 M | -6.48 M | -9.24 M | -24.33 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 19.07% | -12.89% | — | — |
| Earnings Growth % | 127.62% | -148.37% | — | — |
| Profit Margin % | 15.74% | -67.88% | -23.81% | — |
| Operating Margin % | -16.64% | -38.19% | -24% | — |
| Gross Margin % | 67.14% | 63.59% | 65.13% | — |
| EBITDA Margin % | -10.72% | -31.12% | -19.03% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.